| Role |
Name |
Disclosure |
Details |
| Author | Mohsin Ali, MBBS, FRCP, MRCP, MRCPI, Consulting Staff, Department of Dermatology, Amersham General Hospital, UK | Nothing to disclose | Details | | Coauthor | Bassam Zeina, MD, PhD, Consulting Staff, Department of Dermatology, Milton Keynes Hospital, United Kingdom | Nothing to disclose | Details | | Coauthor | Sohail Mansoor, MBBS, MSc, Dermatologist and Lead Physician in Dermatologic Surgery, Department of Dermatology, Barnet Hospital, London, UK | Nothing to disclose | Details | | Medical Editor | Mark G Lebwohl, MD, Chairman, Department of Dermatology, Mount Sinai School of Medicine | Abbott Laboratories Actelion Amgen Astellas Basilea Boehringer-Ingelheim Briston-Myers Squibb Celtic Pharma Centocor Cephalon Chattem DermiPsor Doak DOV Forward Galderma Genentech Genzyme GlaxoSmithKline Graceway Helix BioMedix Isotechnika Ligand Medicis Neosil Novartis OMP Pepgen Pfizer PharmaDerm Roche Stiefel Teva UCB Warner Chilcott | Details | | Pharmacy Editor | David F Butler, MD, Professor of Dermatology, Texas A&M University College of Medicine; Director, Division of Dermatology, Scott and White Clinic; Director Dermatology Residency Training Program, Scott and White Clinic | 3M Pharmaceutical Graceway Pharmaceuticals | Details | | Managing Editor | Christen M Mowad, MD, Assistant Professor, Department of Dermatology, Geisinger Medical Center | Nothing to disclose | Details | | CME Editor | Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University | Nothing to disclose | Details | | Chief Editor | Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Sohail Mansoor, Coauthor |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Christen M Mowad, Managing Editor |
The contributor discloses no conflict of interest. |
|